Delta Wealth Advisors Discloses $110M in Holdings in Q1 2025 13F Filing
Delta Wealth Advisors LLC
Filing Summary
Delta Wealth Advisors Reports $110M AUM in Q1 2025 13F Filing
Filer: Delta Wealth Advisors LLC Form: 13F-HR | Filed: 2025-10-10 Significance: Low
Portfolio Summary: • Total Value: $110,186,613 • Number of Holdings: 40 • Report Period: 2025-03-31
Top Holdings by Value:
- Vanguard S&P 500 ETF ($VOO): $16.2M
- iShares iBonds Dec 2025 Term Treasury ETF ($IBTF): $15.5M
- iShares iBonds Dec 2026 Term Treasury ETF ($IBTG): $11.4M
Key Insight: This is a routine quarterly disclosure of holdings for Delta Wealth Advisors. The portfolio is heavily weighted towards broad-market and fixed-maturity Treasury ETFs, suggesting a diversified, risk-managed strategy for its clients.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Delta Wealth Advisors LLC
Executive Summary
- Trading Significance: Low
- Key Takeaway: Delta Wealth Advisors LLC filed its quarterly Form 13F-HR, disclosing $110.2 million in assets under management as of March 31, 2025. The portfolio shows a strong concentration in diversified ETFs, particularly from Vanguard and iShares.
- Market Impact: As a routine disclosure from an advisory firm of this size, this filing is not expected to have any significant market impact.
Filer Information
| Field | Value |
|---|---|
| Company | Delta Wealth Advisors LLC |
| Ticker Symbol | null |
| CIK | 0001970701 |
| Industry | Investment Advisor |
Insider Information
This filing is a Form 13F-HR, an institutional holdings report, not an insider transaction report (Form 4). The filer is the institution itself.
Portfolio Overview
| Field | Value |
|---|---|
| Form Type | 13F-HR |
| Period of Report | 2025-03-31 |
| Total Holdings Value | $110,186,613 |
| Number of Positions | 40 |
Top 5 Holdings Analysis
| Issuer | Value (USD) | Shares | Portfolio % |
|---|---|---|---|
| VANGUARD INDEX FDS (S&P 500 ETF) | $16,194,429 | 31,512 | 14.7% |
| ISHARES TR (IBONDS 25 TRM TS) | $15,468,252 | 661,885 | 14.0% |
| ISHARES TR (IBONDS 26 TRM TS) | $11,443,344 | 498,838 | 10.4% |
| SPDR SER TR (PORTFOLIO S&P500) | $8,604,433 | 130,846 | 7.8% |
| SPDR INDEX SHS FDS (PORTFOLIO DEVLPD) | $5,595,270 | 153,674 | 5.1% |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a standard, legally required quarterly report of holdings. It does not represent new, market-moving information but rather a snapshot of the firm's positions at the end of the previous quarter. The size of the AUM is not large enough to influence the broader market or the underlying securities.
Volume & Sentiment
- Expected Volume Impact: None. The disclosure is of past positions, not active trading.
- Sentiment Indicator: Neutral. The filing reflects a diversified, ETF-heavy strategy, which is common for wealth advisory firms and does not signal a strong bullish or bearish conviction on any single stock.
Investment Insights
Portfolio Strategy Indicators
- Diversification: The portfolio is highly diversified across 40 positions, with a heavy emphasis on broad-market and international ETFs.
- Fixed Income Exposure: A significant portion of the portfolio (over 24%) is allocated to fixed-maturity Treasury ETFs (iBonds for 2025 and 2026), indicating a strategy to manage interest rate risk and provide predictable returns.
- Core Equity Holdings: The largest single category is S&P 500 ETFs from Vanguard and SPDR, forming a core US large-cap equity base.
Key Takeaways
- ETF-Centric Strategy: Nearly 40% of the firm's reported AUM is concentrated in just three ETF positions (two Treasury bond ETFs and one S&P 500 ETF), highlighting a strategy built on low-cost, diversified funds.
- Risk Management: The substantial allocation to term-specific Treasury ETFs suggests a conservative approach focused on capital preservation and managing duration risk for clients.
- Individual Stock Positions: While the portfolio is ETF-dominant, it holds positions in mega-cap stocks like Apple ($1.3M), Eli Lilly ($0.86M), and Microsoft ($0.61M), likely as satellite holdings around the core ETF base.
Contextual Analysis
Timing Significance
This filing reflects positions held on March 31, 2025, and was filed on October 10, 2025. The data is over six months old and may not represent the firm's current portfolio.
Transaction Context
Form 13F does not show individual buy or sell transactions, only the end-of-quarter holdings. Therefore, it's impossible to determine the cost basis or the timing of the acquisitions from this document alone.
Risk Assessment
Risk Level: Low
Informational Value
- The primary value of this filing is for understanding the asset allocation strategy of a mid-sized registered investment advisor.
- It is not an indicator of near-term performance for any specific security due to the reporting lag and the nature of the holdings.
- The data is historical and should not be used for making timely investment decisions.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-10 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.